Capitol Health Limited (ASX:CAJ – Get Free Report) insider Justin Walter purchased 5,012,530 shares of the stock in a transaction dated Thursday, December 12th. The stock was bought at an average cost of A$0.39 ($0.25) per share, with a total value of A$1,929,824.05 ($1,229,187.29).
Capitol Health Stock Performance
The company has a debt-to-equity ratio of 130.09, a current ratio of 0.44 and a quick ratio of 0.58.
Capitol Health Cuts Dividend
The business also recently declared a Final dividend, which was paid on Sunday, October 20th. Shareholders of record on Sunday, October 20th were given a $0.004 dividend. This represents a yield of 1.25%. The ex-dividend date was Thursday, September 19th. Capitol Health’s payout ratio is -100.00%.
Capitol Health Company Profile
Capitol Health Limited provides diagnostic imaging modalities and related services to the healthcare market in Australia. It offers a range of diagnostic imaging services, including general x-ray, magnetic resonance imaging, ultrasound, mammography, Doppler, orthopantomogram, echocardiography, computed tomography, CT angiography, cone beam CT, nuclear medicine, bone densitometry, and fluoroscopy.
Recommended Stories
- Five stocks we like better than Capitol Health
- Canadian Penny Stocks: Can They Make You Rich?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- Most Volatile Stocks, What Investors Need to Know
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Capitol Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capitol Health and related companies with MarketBeat.com's FREE daily email newsletter.